Nurse Practitioner, Family · Chesapeake, VA
NPI
1427596568
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
713 Volvo Pkwy, Ste 100
Chesapeake, VA, 23320
Phone (757) 609-3404
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
4,358 services
Medicare patients, 2024
376
Average age 72
Drug cost, 2024
$2.3M
3,236 prescriptions
Company payments, 2025
$2,149
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca A Pace was code 99214 (office e&m - established), 997 times for 356 patients. In total Rebecca A Pace billed 4,358 services in 13 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 997 | 356 | $72.19 | $72K |
| 82962 Clinical Chemistry | Office | 995 | 365 | $3.14 | $3,120 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 966 | 357 | $9.68 | $9,349 |
| 83036 Blood Count | Office | 766 | 338 | $9.36 | $7,173 |
| 95251 Test - Miscellaneous | Office | 488 | 196 | $20.70 | $10K |
| G0008 Administration of influenza virus vaccine | Office | 54 | 54 | $31.41 | $1,696 |
| 90662 Vaccine Product | Office | 49 | 49 | $80.81 | $3,960 |
| 99205 Office E&M - New | Office | 18 | 18 | $116.31 | $2,094 |
By year: 2022 $88K for 2,613 services; 2023 $107K for 3,436 services; 2024 $111K for 4,358 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 995 | 365 | $3.14 | $3,120 |
| 83036 Blood Count | 766 | 338 | $9.36 | $7,173 |
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca A Pace prescribed most often to Medicare patients was Ozempic (Semaglutide), with 260 prescriptions and refills. In total Rebecca A Pace wrote 3,236 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 260 | 466 | 63 | $433K |
| Jardiance Empagliflozin | 200 | 438 | 54 | $250K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 196 | 437 | 64 | $31K |
| Mounjaro Tirzepatide | 187 | 306 | 44 | $318K |
| Metformin Hcl Generic | 158 | 410 | 45 | $1,314 |
| Metformin Hcl Er Metformin Hcl | 137 | 395 | 44 | $1,313 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 128 | 360 | 64 | $15K |
| Trulicity Dulaglutide | 122 | 225 | 40 | $214K |
| Humalog Kwikpen U-100 Insulin Lispro | 95 | 199 | 39 | $30K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 90 | 196 | 23 | $53K |
| Atorvastatin Calcium Generic | 76 | 194 | 21 | $610 |
| Omnipod Dash Pods (Gen 4) Insulin Pump Cart,cont Inf,bt | 75 | 120 | 15 | $90K |
| Glimepiride Generic | 67 | 187 | 23 | $363 |
| Insulin Lispro Generic | 66 | 113 | 15 | $7,990 |
| Glipizide Er Glipizide | 60 | 155 | 15 | $694 |
Brand drugs: 1,925 claims; generic drugs: 880 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca A Pace $2,149 ($2,149 in general payments such as food, travel and fees) from 27 companies. The largest payer was Novo Nordisk Inc with $186.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 8 | $186 |
| Amgen Inc. AMGN | 9 | $174 |
| Mannkind Corporation MNKD | 11 | $167 |
| Dexcom, Inc. DXCM | 3 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $159 |
| Abbvie Inc. ABBV | 9 | $143 |
| CeQur Corporation | 1 | $136 |
| Radius Health, Inc. | 4 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $98.59 |
| Xeris Pharmaceuticals, Inc. | 4 | $90.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.